Tokyo Tape
Sign in
← Japan System Techniques

Quarterly report · Q2

4323.TEDINET S100S8RU
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥12.1bn2023-04-01 → 2023-09-30Cons.Net sales
Revenue¥23.5bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥11.0bn2022-04-01 → 2022-09-30Cons.Net sales
Operating income¥1.0bn2023-04-01 → 2023-09-30Cons.Operating income
Operating income¥1.0bn2022-04-01 → 2022-09-30Cons.Operating income
Ordinary income¥1.0bn2023-04-01 → 2023-09-30Cons.Ordinary income
Ordinary income¥2.5bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.0bn2022-04-01 → 2022-09-30Cons.Ordinary income
Profit before tax¥1.0bn2023-04-01 → 2023-09-30Cons.Income before income taxes
Profit before tax¥1.0bn2022-04-01 → 2022-09-30Cons.Income before income taxes
Net income (owners)¥651m2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.8bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥738m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income¥649m2023-04-01 → 2023-09-30Cons.Profit loss
Net income¥748m2022-04-01 → 2022-09-30Cons.Profit loss
Total assets¥18.5bnat 2023-09-30Cons.Assets
Total assets¥17.4bnat 2023-03-31Cons.Assets
Total assets¥15.7bnat 2022-09-30Cons.Total assets (5-year summary)
Total liabilities¥7.4bnat 2023-09-30Cons.Liabilities
Total liabilities¥6.6bnat 2023-03-31Cons.Liabilities
Net assets / equity¥11.1bnat 2023-09-30Cons.Net assets
Net assets / equity¥10.8bnat 2023-03-31Cons.Net assets
Net assets / equity¥9.9bnat 2022-09-30Cons.Net assets (5-year summary)
Cash and deposits¥7.6bnat 2023-09-30Cons.Cash and deposits
Cash and deposits¥7.2bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥7.1bnat 2023-09-30Cons.Cash and cash equivalents
Cash & equivalents¥6.8bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥7.0bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥6.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow¥929m2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥819m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥220m2023-04-01 → 2023-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥542m2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥86m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥409m2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥281m2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥273m2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥53.12023-04-01 → 2023-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥48.062023-07-01 → 2023-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥144.52022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥60.162022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥41.912022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio59.7%at 2023-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio61.8%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio62.5%at 2022-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥89m
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥89m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥1.1bn
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥1.7bn
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥1.7bn
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥34m
jpcrp040300-q2r_E05236-000Global Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥204m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥917m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥917m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥104m
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue2023-04-01 → 2023-09-30¥2.3bn
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue external2023-04-01 → 2023-09-30¥2.3bn
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥407,000
jpcrp040300-q2r_E05236-000Package Businessreportable segmentsegment profit2023-04-01 → 2023-09-30¥601m
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-09-30¥12.2bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-09-30¥12.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-09-30¥89m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-09-30¥2.1bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥89m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥89m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥852m
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥1.4bn
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥1.4bn
jpcrp040300-q2r_E05236-000Global Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥19m
jpcrp040300-q2r_E05236-000Global Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥184m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥719m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥719m
jpcrp040300-q2r_E05236-000Medical Big Data Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥71m
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue2022-04-01 → 2022-09-30¥2.1bn
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue external2022-04-01 → 2022-09-30¥2.1bn
jpcrp040300-q2r_E05236-000Package Businessreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥28m
jpcrp040300-q2r_E05236-000Package Businessreportable segmentsegment profit2022-04-01 → 2022-09-30¥556m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥11.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥11.0bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥89m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥1.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 531
ItemContextValueUnit
Salaries and allowances sgaPrior1YTDDuration708849000JPY
Salaries and allowances sgaCurrentYTDDuration782235000JPY
Provision for bonuses sgaPrior1YTDDuration176740000JPY
Provision for bonuses sgaCurrentYTDDuration199696000JPY
Provision for directors bonuses sgaPrior1YTDDuration34231000JPY
Provision for directors bonuses sgaCurrentYTDDuration44652000JPY
Directors share based compensation expenses sgaPrior1YTDDuration11908000JPY
Directors share based compensation expenses sgaCurrentYTDDuration7945000JPY
Provision for directors retirement benefits sgaPrior1YTDDuration352000JPY
Provision for directors retirement benefits sgaCurrentYTDDuration－JPY
Retirement benefit expenses sgaPrior1YTDDuration28196000JPY
Retirement benefit expenses sgaCurrentYTDDuration31028000JPY
Research and development expenses sgaPrior1YTDDuration199771000JPY
Research and development expenses sgaCurrentYTDDuration120912000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember6870153000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember2051526000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember718883000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember1363476000JPY
Revenues from external customersPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember11004040000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration11004040000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember42063000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember28015000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember18821000JPY
Transactions with other segmentsPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember88900000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-88900000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember6912216000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember2079542000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember718883000JPY
Net salesPrior1YTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember1382298000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember11092940000JPY
Net salesPrior1YTDDuration_ReconcilingItemsMember-88900000JPY
Net salesPrior1YTDDuration11004040000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember1044698000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember555731000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember70923000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember184168000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1855521000JPY
Operating incomePrior1YTDDuration_ReconcilingItemsMember-851927000JPY
Operating incomePrior1YTDDuration1003593000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember7299159000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E05236-000PackageBusinessReportableSegmentMember2255060000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E05236-000MedicalBigDataBusinessReportableSegmentMember917161000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q2r_E05236-000GlobalBusinessReportableSegmentMember1661199000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember12132581000JPY
Revenues from external customersCurrentYTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersCurrentYTDDuration12132581000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q2r_E05236-000DXAndSIBusinessMember54142000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass